The chemical class known as LOC100040682 Inhibitors comprises a series of compounds specifically developed to inhibit the activity of the gene product of LOC100040682. This gene, identified through comprehensive genomic studies, is known to play a critical role in a variety of cellular processes. The function of LOC100040682 is particularly context-dependent, which means that its role can vary significantly depending on the cellular environment and external stimuli. The inhibitors targeting LOC100040682 are designed to selectively interact with the proteins or enzymes produced as a result of the gene's expression. This interaction is of paramount importance as it directly affects the biochemical pathways in which the LOC100040682 gene product is involved. By modulating the activity of this gene product, these inhibitors aim to influence the associated cellular mechanisms and functions.
Developing LOC100040682 Inhibitors is an intricate and multidisciplinary process, involving insights from molecular biology, chemistry, and bioinformatics. The initial phase of this development revolves around understanding the structure and function of the target gene product. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling play crucial roles in this process. These techniques enable researchers to decipher the complex structure of the target molecule, which is essential for the rational design of effective and specific inhibitors. Typically, these inhibitors are small molecules, crafted to penetrate cellular membranes efficiently and establish a stable and potent interaction with their target. The molecular structure of these inhibitors is meticulously designed to ensure robust interactions with the target molecule, often involving the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The effectiveness of these inhibitors is evaluated through various biochemical assays, which measure their ability to inhibit the activity of the gene product in vitro. These studies are vital in determining the potency, selectivity, and general behavior of these inhibitors in controlled conditions, providing a foundation for further exploration of their interactions and effects.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, potentially reducing gene expression globally. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II which is critical for mRNA synthesis, potentially lowering gene transcription. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II transcriptional elongation, potentially affecting gene expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Known to inhibit transcription by affecting the activity of RNA polymerase II. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Terminates mRNA chain elongation, potentially suppressing gene expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Inhibits CDK9, a component of the positive transcription elongation factor b, which is essential for RNA polymerase II-dependent transcription. | ||||||
ICRF-193 | 21416-68-2 | sc-200889 sc-200889A | 1 mg 5 mg | $341.00 $927.00 | 7 | |
Binds to DNA topoisomerase II, inhibiting its decatenation activity and affecting transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Targets DNA topoisomerase I, preventing DNA relegation during transcription and thus inhibiting gene expression. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Forms DNA adducts leading to transcriptional inhibition due to DNA damage. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
May alter gene expression profiles through various signaling pathways, though not a direct inhibitor of transcription. | ||||||